6.5 C
New York
Wednesday, July 6, 2022

COVID Rebound Symptoms After Paxlovid Treatment – Here’s What You Need to Know

Must Read

New Vulnerability Found In The HIV Could Be Targeted With Drugs

For new treatments to be developed that could benefit the almost 40 million people living with HIV...

The Strange Condition That Can Make Your Heartbeat Irregular

Patients with heart failure who are grieving or mourning the loss of a close family member had...

This Is What Makes A Healthy Brain Turn Into Alzheimer’s One – New Research

A new study has identified one of the driving forces behind Alzheimer’s Disease, the most common form...
Aakash Molpariya
Aakash started in Nov 2018 as a writer at Revyuh.com. Since joining, as writer, he is mainly responsible for Software, Science, programming, system administration and the Technology ecosystem, but due to his versatility he is used for everything possible. He writes about topics ranging from AI to hardware to games, stands in front of and behind the camera, creates creative product images and much more. He is a trained IT systems engineer and has studied computer science. By the way, he is enthusiastic about his own small projects in game development, hardware-handicraft, digital art, gaming and music. Email: aakash (at) revyuh (dot) com

The results of 483 high-risk individuals treated with COVID-19 with a five-day oral combination of nirmatrelvir and ritonavir, marketed as Paxlovid, were evaluated by Mayo Clinic researchers.

Only a few people suffered COVID-19 rebound symptoms, and the researchers said additional research is needed to figure out why.

Overall, everyone in the study benefited from the treatment. All of the patients healed, including those who experienced modest rebound symptoms. The research was published in Clinical Infectious Diseases.

Senior author Aditya Shah, M.B.B.S., a Mayo Clinic infectious diseases physician and researcher, adds, “We found that rebound phenomenon was uncommon in this group of patients.”

“The four individuals who experienced rebound (symptoms) represent only 0.8% of the group,” according to the study author, “and all of them recovered quickly without additional COVID-directed therapy.”

The majority of the patients had been vaccinated, with many receiving additional shots. The average age was 63 years old. Despite the fact that these patients were at high risk for COVID, none of them was immunocompromised. Only two people were admitted to the hospital, and they were not for COVID-19-related causes.

The research focuses on four patients who experience rebound symptoms:

  • 19 days after treatment, a 75-year-old male with coronary artery disease experienced a rise in cough and muscle aches.
  • Six days after treatment, a 40-year-old woman with obesity, hypertension, and kidney disease reported lethargy and a sore throat.
  • A 69-year-old man with hypertension and obesity had nasal discharge and cough 10 days after starting treatment.
  • The patient was a 70-year-old male with a history of prostate cancer, obesity, hypertension, and high cholesterol who experienced substantial sinus congestion 10 days following treatment.

Why did some people bounce back?

Researchers believe that a replication of the SARS-CoV-2 virus, which causes COVID-19, may have caused a secondary immune response, which manifested as moderate COVID-19 symptoms. They propose that further prospective studies be conducted to answer the topic. They also point out that all four patients with rebound symptoms had a slew of major health issues known as comorbidities, which has been found to make recovery more difficult. And before becoming infected with COVID-19, all four patients had been vaccinated for more than 90 days.

Image Credit: Getty

You were reading: COVID Rebound Symptoms After Paxlovid Treatment – Here’s What You Need to Know

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -